Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory <i>ALK</i>-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501).

Watanabe, Satoshi; Sakai, Kazuko; Matsumoto, Naoya; Koshio, Jun; Ishida, Akira; Abe, Tetsuya; Ishikawa, Daisuke; Tanaka, Tomohiro; Aoki, Ami; Kajiwara, Tomosue; Koyama, Kenichi; Miura, Satoru; Goto, Yuka; Sekiya, Tomoki; Suzuki, Ryo; Kushiro, Kohei; Fujisaki, Toshiya; Yanagimura, Naohiro; Ohtsubo, Aya; Shoji, Satoshi; Nozaki, Koichiro; Saida, Yu; Yoshizawa, Hirohisa; Nishio, Kazuto; Kikuchi, Toshiaki

Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory ALK-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501).

Watanabe, Satoshi; Sakai, Kazuko; Matsumoto, Naoya; Koshio, Jun; Ishida, Akira; Abe, Tetsuya; Ishikawa, Daisuke; Tanaka, Tomohiro; Aoki, Ami; Kajiwara, Tomosue; Koyama, Kenichi; Miura, Satoru; Goto, Yuka; Sekiya, Tomoki; Suzuki, Ryo; Kushiro, Kohei; Fujisaki, Toshiya; Yanagimura, Naohiro; Ohtsubo, Aya; Shoji, Satoshi; Nozaki, Koichiro; Saida, Yu; Yoshizawa, Hirohisa; Nishio, Kazuto; Kikuchi, Toshiaki.

Afiliación

Watanabe S; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
Sakai K; Department of Genome Biology, Kindai University Faculty of Medicine, Osaka 589-8511, Japan.
Matsumoto N; Department of Respiratory Medicine, Nishiniigata Chuo National Hospital, Niigata 951-8510, Japan.
Koshio J; Department of Respiratory Medicine, Nagaoka Red Cross Hospital, Nagaoka 940-2085, Japan.
Ishida A; Department of Respiratory Medicine, Nagaoka Red Cross Hospital, Nagaoka 940-2085, Japan.
Abe T; Department of Respiratory Medicine, Niigata City General Hospital, Niigata 951-8510, Japan.
Ishikawa D; Department of Respiratory Medicine, Niigata Prefectural Shibata Hospital, Niigata 951-8510, Japan.
Tanaka T; Department of Respiratory Medicine, Niigata Prefectural Central Hospital, Joetsu 943-0892, Japan.
Aoki A; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
Kajiwara T; Department of Respiratory Medicine, Niigata Prefectural Central Hospital, Joetsu 943-0892, Japan.
Koyama K; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
Miura S; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata 951-8510, Japan.
Goto Y; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata 951-8510, Japan.
Sekiya T; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata 951-8510, Japan.
Suzuki R; Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata 951-8510, Japan.
Kushiro K; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
Fujisaki T; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
Yanagimura N; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
Ohtsubo A; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
Shoji S; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
Nozaki K; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
Saida Y; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
Yoshizawa H; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
Nishio K; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
Kikuchi T; Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.

Cancers (Basel) ; 15(1)2022 Dec 29.

Article en En | MEDLINE | ID: mdl-36612200

Palabras clave

alectinib; anaplastic lymphoma kinase (ALK); bevacizumab; ctDNA; non-small-cell lung cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Japón